Exhibit 1 Top Alliances In April 2012 90 *Potential Deal Value is the sum of up-front fees plus disclosed pre-commercialization money. Elsevier’s Strategic Transactions Exhibit 2 Top Mergers & Acquisi
IN VITRO DIAGNOSTICS Mergers & Acquisitions Abingdon Health Ltd. Molecular Vision Ltd. Abingdon Health Ltd. has purchased a 50.1% equity stake in fellow private diagnostics firm Molecular Vision
Merck & Co. Inc. has added early-stage life science venture firm Flagship Ventures to the roster of venture funds it has joined as a limited partner, the firms said Tuesday, April 10. The investment